This is the authors' abstract. We don't add key points for this paper.
Dermatoporosis: a further step to recognitionIn this issue, Humbert et al. 1 report on 'Bateman purpura (Dermatoporosis): a localized scurvy treated by topical vitamin C -double-blind randomized placebo-controlled clinical trial'.The authors have to be acknowledged for conducting this study that focuses on one sign, often the earlier one, of dermatoporosis.They conclude that, as the forearm treated with a topical cosmeceutical containing 5% of vitamin C showed less signs after 12 weeks compared to a 'neutral cream', the purpura of dermatoporosis is due to vitamin C deficiency.It is not our wish to argue with the authors on the many potential interpretations behind this claim.Rather we appreciate that such a study contributes to a better understanding and recognition of dermatoporosis as a significant skin problem in the elderly.Skin ageing has long been considered only as a cosmetic issue.However, with increasing lifespan, we experience a functional dimension of skin ageing which extends beyond cosmetics and appearance.Ten years ago, we proposed the neologism dermatoporosis to cover different characteristics of a chronic cutaneous insufficiency/fragility syndrome, to understand underlying molecular mechanisms and to develop preventative or therapeutic strategies.2,3
No takes yet. Share an insight, caveat, or question.
Kaya et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: